About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
Since Congress enacted the Biologics Price Competition and Innovation Act (BPCIA) in 2010, biosimilars have bolstered competition and increased options for patients. As more biosimilars and interchangeable biosimilars are anticipated to enter the market in the years ahead, competition and savings are expected to grow substantially. But more can be done to realize the full potential of the biosimilar marketplace by addressing market distortions that impede more robust competition and savings from biosimilars, particularly when they could offer lower out-of-pocket costs for patients.
male scientist looking though microscope
Report
The U.S. Biosimilars Market Continues to Increase Competition and Savings but Reforms are Needed to Realize Its Full Potential
male scientist looking though microscope